Southern Spine, LLC
$4.8K 2 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Vioptix Inc
Vioptix Inc reported $4,749.49 across General Payments, Research, and Ownership to 73 physicians and teaching hospitals across 73 transactions.
- $4.7K
- All-tracks total
- 73
- Transactions
- 73
- Recipients
- +$1.2K
- General Payments vs PY2023
Vioptix Inc reported $4,749.49 across all CMS Open Payments tracks (General + Research + Ownership) to 73 physicians and teaching hospitals in Program Year 2024 - ranking #1720 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $4,749.49, averaging $65.06 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer vioptix-inc Vioptix Inc
$4.7K · #1720/1,925 · 0.0% industry · PY2024
- TOT $4.7K
- RANK #1720
- SHARE 0.0%
- TXN 73
- RCP 73
- CAT 2
- GEN $4.7K
- ΔGEN +$1.2K
- TOP1 28.5%
- PY 2024
Volume peers
Nearest volume peer: Southern Spine, LLC ($4.8K)
Vioptix Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Vioptix Inc's CMS-reported General Payments increased by $1.2K (+35.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: VIOPTIX INCPY2023: VIOPTIX INCPY2024: Vioptix Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $3,512.18
- PY2024
- $4,749.49
What the Data Shows for Vioptix Inc
Vioptix Inc ranks #1720 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $4,749.49 across 73 transactions to 73 physicians and teaching hospitals - $65.06 per transaction and $65.06 per recipient on average.
Of the 2 general-payment categories charted below, "Food and Beverage" is the largest at $4.5K across 72 transactions, 94.7% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Vioptix Inc made 2 types of general payments. "Food and Beverage" is the largest category at $4.5K, 94.7% of General Payments.
How Vioptix Inc divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $4.5K | 72 | 94.7% |
| Consulting Fee | $250.00 | 1 | 5.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,114.22 (44.5%) of $4,749.49 in this company's General Payments records across 64 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Vioptix Inc
The five named recipients with the highest reported General Payments from this company
- 1
Elisabeth Potter
$1,353.49 across 2 reported transactions
- 2
Alexandra Kejner
$250.00 across 1 reported transactions
- 3
Kristen Rezak
$183.12 across 2 reported transactions
- 4
Eliza-Jasmine Tran
$174.47 across 2 reported transactions
- 5
Justin Van Hoorebeke
$153.14 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Vioptix Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Vioptix Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Vioptix Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Ortho Technology, Inc
$4.7K 14 recipients
Compare payment profiles
Winter Innovations, Inc.
$4.7K 7 recipients
Compare payment profiles
Sensus Healthcare, Inc.
$4.7K 128 recipients
Compare payment profiles
Linus Health, Inc.
$4.8K 338 recipients
Compare payment profiles
Asuragen, Inc.
$4.9K 6 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.